Jianping Zeng

Showing 1-7 of 7 articles

Other

Prewire channel stent: a novel stent for bifurcation lesions in a pig model

Tang L, Lu G, Feng J, Zhang W, Zeng Y

February 2, 2018 | 10.4244/EIJ-D-17-00513

Coronary interventions

Change in lumen eccentricity and asymmetry after treatment with Absorb bioresorbable vascular scaffolds in the ABSORB cohort B trial: a five-year serial optical coherence tomography imaging study

Suwannasom P, Sotomi Y, Asano T, Koon J, Tateishi H, Zeng Y, Tenekecioglu E, Wykrzykowska J, Foin N, de Winter R, Ormiston J, Serruys P, Onuma Y

April 7, 2017 | 10.4244/EIJ-D-16-00740

Coronary interventions

Non-invasive Heart Team assessment of multivessel coronary disease with coronary computed tomography angiography based on SYNTAX score II treatment recommendations: design and rationale of the randomised SYNTAX III Revolution trial

Cavalcante R, Onuma Y, Sotomi Y, Collet C, Thomsen B, Rogers C, Zeng Y, Tenekecioglu E, Asano T, Miyazaki Y, Abdelghani M, Morel M, Serruys P

March 20, 2017 | 10.4244/EIJ-D-16-00612

Coronary interventions

Comparative analysis method of permanent metallic stents (XIENCE) and bioresorbable poly-L-lactic (PLLA) scaffolds (Absorb) on optical coherence tomography at baseline and follow-up

Nakatani S, Sotomi Y, Ishibashi Y, Grundeken M.J, Tateishi H, Tenekecioglu E, Zeng Y, Suwannasom P, Regar E, Radu M, Räber L, Bezerra H, Costa M, Fitzgerald P, Prati F, Costa R, Dijkstra J, Kimura T, Kozuma K, Tanabe K, Akasaka T, Di Mario C, Serruys P, Onuma Y

December 20, 2016 | 10.4244/EIJY15M10_03

Coronary interventions

Preclinical assessment of the endothelial shear stress in porcine-based models following implantation of two different bioresorbable scaffolds: effect of scaffold design on the local haemodynamic micro-environment

Tenekecioglu E, Torii R, Bourantas C, Crake T, Zeng Y, Sotomi Y, Onuma Y, Yılmaz M, Santoso T, Serruys P

November 20, 2016 | 10.4244/EIJY16M05_01

Coronary interventions

Is quantitative coronary angiography reliable in assessing the lumen gain after treatment with the everolimus-eluting bioresorbable polylactide scaffold?

Sotomi Y, Onuma Y, Suwannasom P, Tateishi H, Tenekecioglu E, Zeng Y, Cavalcante R, Jonker H, Dijkstra J, Foin N, Koon J, Collet C, de Winter R, Wykrzykowska J, Stone G, Popma J, Kozuma K, Tanabe K, Serruys P, Kimura T

October 10, 2016 | 10.4244/EIJV12I8A163

Interventions for valvular disease

The Sino Medical AccuFit transcatheter mitral valve implantation system

Abdelghani M, Onuma Y, Zeng Y, Soliman O, Ma J, Huo Y, Guidotti A, Nietlispach F, Maisano F, Serruys P

September 17, 2015 | 10.4244/EIJV11SWA26

1

Latest news

Robotics, AI and Imaging State of The Art; Bleeding Risk and Mortality in CAD; Treating Refractory Angina by Coronary Sinus Narrowing; and more

September 20, 2021

STATE OF THE ART

Robotics, imaging, and artificial intelligence in the catheterisation laboratory

Rafael Beyar et al.

September 20, 2021

ViV TAVI vs repeat SAVR

Monil Majmundar et al.

September 15, 2021

Thrombectomy for ischaemic stroke

Christopher A. Rajkumar et al.

September 10, 2021

Walking the tightrope between ischaemia and bleeding

Michelle L. O’Donoghue et al.

September 20, 2021

Microvascular dysfunction endotypes and outcomes

Christos V. Bourantas et al.

September 20, 2021

Coronary sinus reducer therapy for refractory angina: is it ready for prime time?

Michael Foley et al.

September 20, 2021

Valvular disease